EcoR1 Capital, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$25,196,000
-63.6%
1,249,812
-54.1%
0.88%
-82.8%
Q2 2020$69,139,000
+12.5%
2,721,993
-18.7%
5.11%
-20.5%
Q1 2020$61,472,000
-23.1%
3,346,301
-7.8%
6.42%
-10.8%
Q4 2019$79,916,000
+40.4%
3,627,597
-8.5%
7.20%
+0.2%
Q3 2019$56,908,000
+9.0%
3,962,978
+19.5%
7.19%
+36.2%
Q2 2019$52,233,000
+7.5%
3,316,4070.0%5.28%
+17.8%
Q1 2019$48,585,000
+37.0%
3,316,4070.0%4.48%
+26.3%
Q4 2018$35,452,000
-38.9%
3,316,407
-12.8%
3.55%
-32.1%
Q3 2018$58,024,000
+60.0%
3,802,327
+28.4%
5.23%
+51.4%
Q2 2018$36,274,000
-20.4%
2,961,147
-37.8%
3.45%
-24.4%
Q1 2018$45,548,000
+4.3%
4,764,447
-1.5%
4.57%
-7.1%
Q4 2017$43,674,000
+692.9%
4,836,547
+404.9%
4.92%
+570.0%
Q3 2017$5,508,000
+126.2%
957,992
+24.7%
0.73%
+69.9%
Q2 2017$2,435,000
+87.5%
767,992
+101.0%
0.43%
+31.7%
Q1 2017$1,299,000382,0000.33%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders